Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

15.33
+0.63004.29%
Post-market: 15.420.0900+0.59%19:58 EST
Volume:1.07M
Turnover:16.29M
Market Cap:1.27B
PE:-5.11
High:15.44
Open:14.58
Low:14.20
Close:14.70
52wk High:19.11
52wk Low:3.91
Shares:82.79M
Float Shares:59.91M
Volume Ratio:0.35
T/O Rate:1.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9984
EPS(LYR):-2.3246
ROE:-98.23%
ROA:-49.39%
PB:6.34
PE(LYR):-6.59

Loading ...

EyePoint Chief Medical Officer Ramiro Ribeiro Disposes of Common Shares

Reuters
·
Feb 19

EyePoint Names Michael Campbell Chief Commercial Officer

Reuters
·
Feb 18

EyePoint Appoints Michael Campbell as Chief Commercial Officer

THOMSON REUTERS
·
Feb 18

BRIEF-Eyepoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Feb 17

EyePoint Grants Stock Options to New Employees as Inducement Awards

Reuters
·
Feb 17

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 17

EyePoint Inc. nimmt am Guggenheim Emerging Outlook: Biotech Summit teil

Reuters
·
Feb 05

EyePoint Grants Stock Options to New Employees as Inducement Awards

Reuters
·
Jan 16

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 16

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 16

EyePoint Pharmaceuticals: Advancing DURAVYU Phase 3 Programs with Strong Cash Runway Supports Buy Rating and $23 Target

TIPRANKS
·
Jan 08

EyePoint Inc. Chief Medical Officer Ramiro Ribeiro Reports Disposal of Common Shares

Reuters
·
Jan 08

EyePoint Inc. to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 07

EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026

GlobeNewswire
·
Jan 07

The Year-End 2025 Biotech Rally And What It Means For 2026

Benzinga_recent_news
·
Dec 31, 2025

EyePoint (EYPT) Valuation Check as Upgraded Earnings Estimates Fuel Strong Share Price Momentum

Simply Wall St.
·
Dec 24, 2025

BRIEF-Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Dec 16, 2025

EyePoint Grants Stock Options to New Employees as Inducement Awards

Reuters
·
Dec 16, 2025

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 16, 2025

After Leaping 38% EyePoint, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar

Simply Wall St.
·
Dec 13, 2025